AstraZeneca, Avillion Land FDA Approval for First of Its Kind Asthma Inhaler
The FDA approved Airsupra, an asthma rescue inhaler that administers two different medications, one that opens up airways and another that treats inflammation. The inhaler stems from a partnership between AstraZeneca and Avillion.